161 related articles for article (PubMed ID: 32168859)
1. Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21.
Hernández-Walias FJ; Vázquez E; Pacheco Y; Rodríguez-Fernández JM; Pérez-Elías MJ; Dronda F; Casado JL; Moreno A; Hermida JM; Quereda C; Hernando A; Tejerina-Picado F; Asensi V; Galindo MJ; Leal M; Moreno S; Vallejo A
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32168859
[TBL] [Abstract][Full Text] [Related]
2. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
[No Abstract] [Full Text] [Related]
3. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.
Paydas S; Acikalin A; Ergin M; Celik H; Yavuz B; Tanriverdi K
Med Oncol; 2016 Apr; 33(4):34. PubMed ID: 26951445
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.
Plattel WJ; Alsada ZN; van Imhoff GW; Diepstra A; van den Berg A; Visser L
Br J Haematol; 2016 Dec; 175(5):868-875. PubMed ID: 27610595
[TBL] [Abstract][Full Text] [Related]
5. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
7. Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma.
Lievin R; Hendel-Chavez H; Baldé A; Lancar R; Algarte-Génin M; Krzysiek R; Costagliola D; Assoumou L; Taoufik Y; Besson C
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008292
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Nourse JP; Keane C; Bhatnagar A; Gandhi MK
Clin Cancer Res; 2014 Jan; 20(1):253-64. PubMed ID: 24222179
[TBL] [Abstract][Full Text] [Related]
9. Function and mechanisms of microRNA-20a in colorectal cancer.
Xiao Z; Chen S; Feng S; Li Y; Zou J; Ling H; Zeng Y; Zeng X
Exp Ther Med; 2020 Mar; 19(3):1605-1616. PubMed ID: 32104211
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer.
Zhang H; Mao F; Shen T; Luo Q; Ding Z; Qian L; Huang J
Oncol Lett; 2017 Feb; 13(2):669-676. PubMed ID: 28356944
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy.
Umino K; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Ann Hematol; 2019 Sep; 98(9):2121-2129. PubMed ID: 31240469
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
[TBL] [Abstract][Full Text] [Related]
13. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
14. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
16. The Role of MicroRNA Signature as Diagnostic Biomarkers in Different Clinical Stages of Colorectal Cancer.
Eslamizadeh S; Heidari M; Agah S; Faghihloo E; Ghazi H; Mirzaei A; Akbari A
Cell J; 2018 Jul; 20(2):220-230. PubMed ID: 29633600
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.
Gysler SM; Mulla MJ; Guerra M; Brosens JJ; Salmon JE; Chamley LW; Abrahams VM
Mol Hum Reprod; 2016 Jul; 22(7):465-74. PubMed ID: 27029214
[TBL] [Abstract][Full Text] [Related]
18. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
[TBL] [Abstract][Full Text] [Related]
19. Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses.
Hosnijeh FS; Portengen L; Späth F; Bergdahl IA; Melin B; Mattiello A; Masala G; Sacerdote C; Naccarati A; Krogh V; Tumino R; Chadeau-Hyam M; Vineis P; Vermeulen R
Int J Cancer; 2016 May; 138(10):2357-67. PubMed ID: 26684261
[TBL] [Abstract][Full Text] [Related]
20. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
